However, cotrimoxazole resistance was higher among PLHIV than among people, which could be the result of cotrimoxazole prophylaxis provided to PLHIV for treatment of opportunistic infections [59], and cotrimoxazole prophylaxis is given to HIV-infected adults with a CD4 count of <500 cells/μl in Nepal [47]. Here, CD4 is linked to Opportunistic infection.